Sample pages - Gale

Major Pharmaceutical 

and Biotechnology 

Companies 

of the World 2012 

Editors 

Layla Comstive 

Susan Hoernig 

Sue Ward 

Australia • Brazil • Japan • Korea • Mexico • Singapore • Spain • United Kingdom • United States

Contents 

Major Pharmaceutical and Biotechnology Companies of the World 2012 

Africa (South of the Sahara) 

Angola. . . . . . . . . . . . . . . . . . . . . . . . . . .1 

Benin . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 

Botswana . . . . . . . . . . . . . . . . . . . . . . . . 1 

Burkina Faso . . . . . . . . . . . . . . . . . . . . . . 1 

Cameroon . . . . . . . . . . . . . . . . . . . . . . . . 1 

Cape Verde . . . . . . . . . . . . . . . . . . . . . . . 1 

Democratic Republic of the Congo . . . . . 1 

Ethiopia . . . . . . . . . . . . . . . . . . . . . . . . . . 2 

Gabon . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 

Ghana . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 

Ivory Coast . . . . . . . . . . . . . . . . . . . . . . . 3 

Kenya . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 

Lesotho . . . . . . . . . . . . . . . . . . . . . . . . . . 4 

Madagascar . . . . . . . . . . . . . . . . . . . . . . 4 

Malawi . . . . . . . . . . . . . . . . . . . . . . . . . . 4 

Mali . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 

Mauritius . . . . . . . . . . . . . . . . . . . . . . . . .5 

Mozambique . . . . . . . . . . . . . . . . . . . . . . 5 

Niger . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 

Nigeria . . . . . . . . . . . . . . . . . . . . . . . . . . 5 

Republic of the Congo . . . . . . . . . . . . . . 7 

Senegal . . . . . . . . . . . . . . . . . . . . . . . . . . 7 

South Africa . . . . . . . . . . . . . . . . . . . . . . 8 

Swaziland . . . . . . . . . . . . . . . . . . . . . . . 15 

Togo . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 

Uganda . . . . . . . . . . . . . . . . . . . . . . . . . 16 

Zambia . . . . . . . . . . . . . . . . . . . . . . . . . 16 

Zimbabwe . . . . . . . . . . . . . . . . . . . . . . . 16 

Arab World 

Algeria . . . . . . . . . . . . . . . . . . . . . . . . . 16 

Bahrain . . . . . . . . . . . . . . . . . . . . . . . . . 17 

Egypt. . . . . . . . . . . . . . . . . . . . . . . . . . .17 

Gaza and West Bank . . . . . . . . . . . . . . 23 

Iraq . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 

Jordan . . . . . . . . . . . . . . . . . . . . . . . . . 24 

Kuwait. . . . . . . . . . . . . . . . . . . . . . . . . .27 

Lebanon . . . . . . . . . . . . . . . . . . . . . . . . 30 

Libyan Arab Jamahiriya . . . . . . . . . . . . 32 

Mauritania . . . . . . . . . . . . . . . . . . . . . . 32 

Morocco . . . . . . . . . . . . . . . . . . . . . . . . 32 

Oman . . . . . . . . . . . . . . . . . . . . . . . . . . 34 

Qatar. . . . . . . . . . . . . . . . . . . . . . . . . . .35 

Saudi Arabia . . . . . . . . . . . . . . . . . . . . . 36 

Sudan . . . . . . . . . . . . . . . . . . . . . . . . . . 45 

Syrian Arab Republic . . . . . . . . . . . . . . 46 

Tunisia . . . . . . . . . . . . . . . . . . . . . . . . . 48 

United Arab Emirates . . . . . . . . . . . . . . 49 

UAE (Abu Dhabi) . . . . . . . . . . . . . . . . . . 49 

UAE (Dubai) . . . . . . . . . . . . . . . . . . . . . 49 

UAE (Fujairah) . . . . . . . . . . . . . . . . . . . . 51 

UAE (Ras Al Khaimah) . . . . . . . . . . . . . 51 

UAE (Sharjah) . . . . . . . . . . . . . . . . . . . . 52 

Yemen. . . . . . . . . . . . . . . . . . . . . . . . . .52 

Asia and Australasia 

Australia . . . . . . . . . . . . . . . . . . . . . . . . 53 

Bangladesh. . . . . . . . . . . . . . . . . . . . . .63 

Hong Kong SAR . . . . . . . . . . . . . . . . . . 65 

India . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 

Indonesia . . . . . . . . . . . . . . . . . . . . . . 115 

Iran . . . . . . . . . . . . . . . . . . . . . . . . . . . 119 

Japan . . . . . . . . . . . . . . . . . . . . . . . . . 122 

Malaysia . . . . . . . . . . . . . . . . . . . . . . . 153 

Mongolia. . . . . . . . . . . . . . . . . . . . . . .165 

Myanmar . . . . . . . . . . . . . . . . . . . . . . 165 

Nepal . . . . . . . . . . . . . . . . . . . . . . . . . 165 

New Zealand . . . . . . . . . . . . . . . . . . . 166 

North Korea . . . . . . . . . . . . . . . . . . . . 169 

Pakistan . . . . . . . . . . . . . . . . . . . . . . . 169 

Papua New Guinea. . . . . . . . . . . . . . .171 

People’s Republic of China . . . . . . . . 172 

Philippines . . . . . . . . . . . . . . . . . . . . . 200 

Singapore . . . . . . . . . . . . . . . . . . . . . . 204 

South Korea . . . . . . . . . . . . . . . . . . . . 211 

Sri Lanka . . . . . . . . . . . . . . . . . . . . . . 225 

Taiwan . . . . . . . . . . . . . . . . . . . . . . . . 226 

Thailand . . . . . . . . . . . . . . . . . . . . . . . 235 

Vietnam . . . . . . . . . . . . . . . . . . . . . . . 238 

Eastern Europe and the Commonwealth of 

Independent States 

Albania . . . . . . . . . . . . . . . . . . . . . . . . 242 

Armenia . . . . . . . . . . . . . . . . . . . . . . . 242 

Azerbaijan. . . . . . . . . . . . . . . . . . . . . .242 

Belarus . . . . . . . . . . . . . . . . . . . . . . . . 243 

Bosnia and Herzegovina . . . . . . . . . . . 243 

Croatia . . . . . . . . . . . . . . . . . . . . . . . . 244 

Georgia . . . . . . . . . . . . . . . . . . . . . . . . 245 

Kazakhstan . . . . . . . . . . . . . . . . . . . . . 246 

Macedonia . . . . . . . . . . . . . . . . . . . . . 246 

Moldova . . . . . . . . . . . . . . . . . . . . . . . 247 

Montenegro . . . . . . . . . . . . . . . . . . . . 247 

Russia. . . . . . . . . . . . . . . . . . . . . . . . .247 

Serbia . . . . . . . . . . . . . . . . . . . . . . . . . 261 

Ukraine . . . . . . . . . . . . . . . . . . . . . . . . 262 

Uzbekistan . . . . . . . . . . . . . . . . . . . . . 265 

Europe 

Austria . . . . . . . . . . . . . . . . . . . . . . . . 266 

Belgium . . . . . . . . . . . . . . . . . . . . . . . 271 

Bulgaria . . . . . . . . . . . . . . . . . . . . . . . 280 

Cyprus . . . . . . . . . . . . . . . . . . . . . . . . 281 

Czech Republic. . . . . . . . . . . . . . . . . .282 

Denmark. . . . . . . . . . . . . . . . . . . . . . .287 

Estonia . . . . . . . . . . . . . . . . . . . . . . . . 295 

Finland . . . . . . . . . . . . . . . . . . . . . . . . 295 

France . . . . . . . . . . . . . . . . . . . . . . . . 299 

Germany . . . . . . . . . . . . . . . . . . . . . . . 334 

Greece . . . . . . . . . . . . . . . . . . . . . . . . 365 

Hungary . . . . . . . . . . . . . . . . . . . . . . . 370 

Iceland . . . . . . . . . . . . . . . . . . . . . . . . 376 

Israel. . . . . . . . . . . . . . . . . . . . . . . . . .377 

Italy . . . . . . . . . . . . . . . . . . . . . . . . . . . 383 

Latvia . . . . . . . . . . . . . . . . . . . . . . . . . 395 

Liechtenstein . . . . . . . . . . . . . . . . . . . 396 

Lithuania. . . . . . . . . . . . . . . . . . . . . . .396 

Luxembourg . . . . . . . . . . . . . . . . . . . . 396 

Monaco . . . . . . . . . . . . . . . . . . . . . . . 397 

Netherlands . . . . . . . . . . . . . . . . . . . . 397 

Norway . . . . . . . . . . . . . . . . . . . . . . . . 405 

Poland . . . . . . . . . . . . . . . . . . . . . . . . 409 

Portugal . . . . . . . . . . . . . . . . . . . . . . . 418 

Republic of Ireland . . . . . . . . . . . . . . . 423

IV 

Romania . . . . . . . . . . . . . . . . . . . . . . . 429 

Slovakia . . . . . . . . . . . . . . . . . . . . . . . 431 

Slovenia . . . . . . . . . . . . . . . . . . . . . . . 433 

Spain . . . . . . . . . . . . . . . . . . . . . . . . . 435 

Sweden . . . . . . . . . . . . . . . . . . . . . . . 455 

Switzerland . . . . . . . . . . . . . . . . . . . . . 463 

Turkey . . . . . . . . . . . . . . . . . . . . . . . . . 482 

UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . 485 

Latin America 

Argentina . . . . . . . . . . . . . . . . . . . . . . 513 

Belize . . . . . . . . . . . . . . . . . . . . . . . . . 516 

Bolivia . . . . . . . . . . . . . . . . . . . . . . . . . 516 

Brazil . . . . . . . . . . . . . . . . . . . . . . . . . 517 

CARIBBEAN - Antigua and Barbuda . .528 

CARIBBEAN - Aruba . . . . . . . . . . . . . . 528 

CARIBBEAN - Bahamas . . . . . . . . . . . 528 

CARIBBEAN - Barbados . . . . . . . . . . . 529 

CARIBBEAN - Bermuda . . . . . . . . . . . 529 

CARIBBEAN - Cayman Islands . . . . . . 529 

CARIBBEAN - Dominican Republic. . .529 

CARIBBEAN - Grenada . . . . . . . . . . . . 530 

CARIBBEAN - Jamaica . . . . . . . . . . . . 530 

CARIBBEAN - Puerto Rico . . . . . . . . . 531 

CARIBBEAN - St Lucia . . . . . . . . . . . . 531 

CARIBBEAN - St Vincent and the 

Grenadines. . . . . . . . . . . . . . . . . . . .531 

CARIBBEAN - Trinidad and Tobago . . 531 

Chile . . . . . . . . . . . . . . . . . . . . . . . . . . 532 

Colombia . . . . . . . . . . . . . . . . . . . . . . 535 

Costa Rica . . . . . . . . . . . . . . . . . . . . . 537 

Curacao . . . . . . . . . . . . . . . . . . . . . . . 537 

Ecuador . . . . . . . . . . . . . . . . . . . . . . . 538 

El Salvador . . . . . . . . . . . . . . . . . . . . . 538 

French Guyana . . . . . . . . . . . . . . . . . . 538 

Guatemala . . . . . . . . . . . . . . . . . . . . . 539 

Guyana . . . . . . . . . . . . . . . . . . . . . . . . 539 

Mexico . . . . . . . . . . . . . . . . . . . . . . . . 539 

Nicaragua . . . . . . . . . . . . . . . . . . . . . . 546 

Panama . . . . . . . . . . . . . . . . . . . . . . . 546 

Paraguay . . . . . . . . . . . . . . . . . . . . . . 547 

Peru . . . . . . . . . . . . . . . . . . . . . . . . . . 547 

Suriname . . . . . . . . . . . . . . . . . . . . . . 548 

Uruguay . . . . . . . . . . . . . . . . . . . . . . . 548 

Venezuela . . . . . . . . . . . . . . . . . . . . . . 549 

North America 

Indexes 

Canada . . . . . . . . . . . . . . . . . . . . . . . . 551 

USA . . . . . . . . . . . . . . . . . . . . . . . . . . 557 

Alphabetical Index . . . . . . . . . . . . . . . 595 

Index by Country . . . . . . . . . . . . . . . . 625

00936 CHEMI DAROU INDUSTRIAL COMPANY IRAN 

Status: Private Company 

00936 

CHEMI DAROU INDUSTRIAL COMPANY 

Address: PO Box 16575-361, Next to Saipa Co, 3km Mark, 

Abali Road, Tehran 

International tel: +98 (21) 7733 0291 

International fax: +98 (21) 7733 6458 

Company email: info@chemidarou.com 

Website: www.chemidarou.com 

Board of Directors: Ali Jabbari (Managing Director) 

PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals, 

polyvinyl acetate resins and textile auxiliaries 

Ticker Symbol: KIMI1 

Stock Exchange: TSE 

ISIN: IRO1KIMI0001 

Status: Public Company 

Date of Establishment: 1965 

No of Employees: 350 

Financial Information: 

20.3.10 20.3.11 

IR’000 IR’000 

Sales turnover 498,833,000 450,475,000 

Profit before tax 143,277,000 134,427,000 

Profit after tax 112,370,000 115,478,000 

Earnings per share IR936 IR481 

Share capital 120,000,000 240,000,000 

Shareholders’ equity 333,545,000 370,223,000 

00937 

CINNAGEN COMPANY 

Address: 5th Floor, 56 Azimi St, Phase 1, Shahrak Ekbatan, 

Tehran 



Company email: info@cinnagen.com;sales@cinnagen.com 

Website: www.cinnagen.com 

Management: Dr Haleh Hamedifar (President) 

PRINCIPAL ACTIVITIES: Molecular biology and biotechnology 

company, producing diagnostic/research reagents including 

blood grouping reagents, PCR kits and reagents, HIV kits, 

T3 T4 kits, LHRH, molecular biology reagents and CA, PH 

and CL diagnostic kits 



00938 

COSAR PHARMACEUTICAL COMPANY 

Address: 32, 6th Alley, Ahmad Qasir Street, Abbas Abad 

Street, 15147-17811 Tehran 



Telex: 223243 CSPH-IR 

Website: www.cosarpharm.com 

Board of Directors: Faramarz Shariat (Managing Director) 

PRINCIPAL ACTIVITIES: Manufacture and idstribution of pharmaceuticals, 

particularly antibiotic finished products such 

as Ampicillin, Amoxicillin and Cloxacillin 

Major Products: Antibiotics oral forms 

Trade Names: Irapen, Iramox, Cloxiran, Co-Amoxiclav, Garlet 

Principal Banks: Bank Tejarat 

Auditors: Rahbord Argham Co 

Ticker Symbol: DKSR1 


ISIN: IRO1DKSR0001 





20.3.10 20.3.11 

IR’000 IR’000 





Share capital 135,000,000 180,000,000 


120 

00939 

DAMLORAN PHARMACEUTICAL COMPANY 

Address: 7 Parvin Street, West Dr Fatemi Avenue, 14186 

Tehran 

International tel: +98 (21) 6694 5732; +98 (21) 939 690; 

+98 (21) 885 6907 

International fax: +98 (662) 6694 5736 (Factory); 

+98 (21) 651325 

Telex: 212710 DVPL IR 

Company email: damloran@damloran.com 

Website: www.damloran.com/ 

Board of Directors: Ahmad Karbasi (Managing Director) 

PRINCIPAL ACTIVITIES: Manufacture and distribution of 

veterinary pharmaceuticals 

Trade Names: Damloran 

Ticker Symbol: DAML1 


ISIN: IRO1DAML0001 





20.3.10 20.3.11 

IR’000 IR’000 




Earnings per share IR1,367 IR1,544 

Share capital 35,400,000 35,400,000 


00940 

DAROU PAKHSH (HOLDING) COMPANY 

Address: Darou Pakhsh Street, 18km Mark, Tehran-Karaj 

Highway, Tehran 



Company email: info@dppharma.com 

Website: www.dppharma.ir 

Board of Directors: Ahmad Sheybani (Managing Director) 

PRINCIPAL ACTIVITIES: Investment holding company with 

subsidiaries involved in the manufacture and marketing of 

pharmaceuticals 

Subsidiary Companies: (100% owned unless stated): Darou 

Pakhsh Pharmaceuticals Company; Darou Pakhsh Pharmaceuticals 

Manufacturing Company 

Ticker Symbol: DARO1 


ISIN: IRO1DARO0001 


No of Employees: 3,420 


20.3.10 20.3.11 

IR’000 IR’000 

Income 580,950,000 701,416,000 



Earnings per share IR956 IR1,213 

Share capital 600,000,000 600,000,000 

Shareholders’ equity 1,349,373,000 1,583,474,000 

00941 

DAROU PAKHSH PHARMACEUTICALS 

COMPANY 







PRINCIPAL ACTIVITIES: Wholesale of pharmaceuticals 

Parent Company: Darou Pakhsh (Holding) Company (00940) 

Ticker Symbol: DDPK1 


ISIN: IRO1DDPK0001 


Principal Shareholders: Darou Pakhsh (Holding) Company 



20.3.10 20.3.11 

IR’000 IR’000 





Share capital 35,000,000 35,000,000 


00942 

DAROU PAKHSH PHARMACEUTICALS 

MANUFACTURING COMPANY 







PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals 

Parent Company: Darou Pakhsh (Holding) Company (00940) 

Ticker Symbol: DPAK1 


ISIN: IRO1DPAK0001 


Principal Shareholders: Darou Pakhsh (Holding) Company 


20.3.10 20.3.11 

IR’000 IR’000 

Sales turnover 1,003,667,000 1,101,409,000 




Share capital 100,000,000 200,000,000 


00943 

DOCTOR ABIDI LABORATORIES COMPANY 

Address: 8km Mark, Karaj Special Road Boulevard, Tehran 



Company email: info@abidipharma.com 

Website: www.doctor-abidi.com 

Board of Directors: M Hasan Baradaran Ghasemi (Managing 

Director) 


Ticker Symbol: ABDI1 


ISIN: IRO1ABDI0001 




20.3.10 20.3.11 

IR’000 IR’000 





Share capital 56,000,000 56,000,000 


00944 

EXIR PHARMACEUTICAL COMPANY 

Address: PO Box 14335-379, 22 Rahmati Alley, Vali-e Asr, 

Tehran 



Company email: info@exir.co.ir 

Website: exir.co.ir 

Board of Directors: Gholam Hossain Farzandi (Managing 

Director) 


Ticker Symbol: EXIR1 


ISIN: IRO1EXIR0001 


No of Employees: 590

03590 ACINO HOLDING AG SWITZERLAND 

Company email: info.ch@abbott.com 

Website: www.abbott.ch 

Company Registration Number: CH-280.3.910.125-8 

Management Board: Jacopo Andreose (Chairman), Robert 

Lüthi (Member), Peter Reinert (Member) 

PRINCIPAL ACTIVITIES: Development and manufacture of 

pharmaceuticals and nutritional products, and products 

for diabetes care, laboratory diagnostics, vascular disease 

treatment and molecular diagnostics. ISO 9001 and ISO 

14001 certified 

Company History: The company was previously known as 

Knoll AG and subsequently as Abbott Liestal AG 

Branch Offices: Altishofen; Beringen 

Parent Company: Abbott Laboratories, USA 

Principal Banks: UBS 

Auditors: Deloitte AG 


Principal Shareholders: Abbott Laboratories, USA (100%) 


No of Employees: 140 (Company) 300 (Switzerland) 

03590 

ACINO HOLDING AG 

Address: Erlenstrasse 1, 4058 Basel 

International tel: +41 (61) 338 60 00; +41 (61) 775 80 10 

International fax: +41 (61) 338 60 06 

Company email: info@acino-pharma.com 

Website: www.acino-pharma.com 


Board of Directors: Luzi Andreas von Bidder (Chairman), Dr 

René Muttenzer (Vice Chairman), Dr Anders Härfstrand (Director), 

Hans Peter Hasler (Director), Jürg Michel (Director) 

Executive Board: Peter Burema (Chief Executive Officer), Dr 

Jean-Daniel Bonny (Head of Research and Development), 

Dr Annette Eschler (Head of Business Development), Jörg 

Gebhardt (Head of IT and Human Resources), Dr Harald 

Haubitz (Head of Production), Ruud van Anraat (Chief Commercial 

Officer), Marcel von Ah (Chief Financial Officer) 

PRINCIPAL ACTIVITIES: Research, development, manufacture 

and distribution of speciality pharmaceuticals and 

value-added generics 

Company History: September 2008: Schweizerhall Holding 

AG changed its company name to Acino Holding AG. Simultaneously 

the business units Cimex and Novosis joined 

forces under the common company name Acino 

Subsidiary Companies: (100% owned unless stated): Acino 

AG (Germany); Acino Pharma AG; Acino Pharma GmbH 

(Germany); Acino Pharma Inc (USA); Acino Supply AG 

Principal Banks: UBS; CS 

Auditors: PricewaterhouseCoopers AG 

Ticker Symbol: ACIN 

Stock Exchange: Swiss 

ISIN: CH0002159413 


Principal Shareholders: Chase Nominees Ltd, UK (18.2%); 

Marianne and Dr Hans-Peter Schär (8.2%) 

No of Employees: 443 (Group) 

Financial Information: Consolidated figures 

31.12.09 31.12.10 

EUR’000 EUR’000 

Revenue 158,181 127,533 

Profit (loss) before tax 41,837 (6,027) 

Profit after tax 33,501 4,518 

Earnings per share 10.53EUR 1.42EUR 

Share capital 823 823 

Shareholders’ equity 256,017 252,585 

03591 

ACTAVIS 

Actavis Group 

Address: Turmstrasse 24, 6300 Zug 

International tel: +41 (41) 462 73 00 

Website: www.actavis.com 


Executive Board: Dr Claudio Albrecht (Chief Executive Officer), 

Gunnar A Beinteinsson (Executive Vice President. 

Human Resources and OD), Doug Boothe (Executive Vice 

President, Americas Sales), Gudbjorg Edda Eggertsdottir 

(President Iceland, Strategic Projects), Guðrun S Eyjolfsdottir 

(Executive Vice President, Quality and Compliance), 

Mark Keatley (Executive Vice President, Finance), Wolter 

Kuizinga (Executive Vice President, Business Development), 

Roy Papatheodorou (Executive Vice President and General 

Counsel), Preter Prock (Deputy Chief Executive Officer), 

464 

Valur Ragnarsson (Executive Vice President, Third-Party 

Sales), Lars Ramneborn (Executive Vice President, Europe 

Sales), Jeff Rope (Executive Vice President of Operations), 

Frank Staud (Executive Vice President - Corporate Communications, 

Branding and Sponsoring), Stefan J Sveinsson 

(Executive Vice President, Research and Development), 

Hordur Thorhallsson (Executive Vice President, MEA and 

Asia Pacific Sales) 

PRINCIPAL ACTIVITIES: Production of generic pharmaceuticals 

Company History: The company was privatised in 2007. In 

May 2011 it moved its headquarters to Switzerland 

Branch Offices: Bulgaria; Iceland; India; Indonesia; Italy; 

Malta; PRC; Romania; Russia; Serbia; UK; USA 

Subsidiary Companies: (100% owned unless stated): Actavis 

Deutschland GmbH & Co KG (Germany); Actavis EAD 

(Bulgaria); Actavis Operations EOOD (Bulgaria); Actavis 

Pharma Development Centre Private Limited (India); Actavis 

Romania SRL (Romania); Actavis UK Limited (UK) 



No of Employees: 10,000 (Worldwide) 

03592 

ACTELION PHARMACEUTICALS LTD 

Address: Gewerbestrasse 16, 4123 Allschwil 

International tel: +41 (61) 565 65 65; 

+41 (61) 487 34 58 (Media/Investor Contacts) 


Company email: info@actelion.com;jobs.ch@actelion.com 

Website: www.actelion.com 


Board of Directors: Jean-Pierre Garnier (Chairman), Jean- 

Paul Clozel (Chief Executive Officer), Juhani Anttila (Director), 

Robert Bertolini (Director), Marian Borovsky (Senior 

Vice President, Group General Counsel and Corporate 

Secretary), Robert E Cawthorn (Director), Carl Feldbaum 

(Director), Werner Henrich (Director), Michael Jacobi (Director), 

Armin Kessler (Director), Jean Malo (Director) 

Executive Committee: Christian Albrich (Senior Vice President 

and Head of Global Human Resources), Guy Braunstein (Executive 

Vice President and Head of Clinical Development), 

Roland Haefeli (Senior Vice President and Head of Investor 

Relations and Public Affairs) 

Management Board: Simon Buckingham (Senior Global 

Advisor), Louis de Lassence (Vice President and Head of 

Corporate Services), Nicholas Franco (Executive Vice President 

and Chief Business Development Officer), Isaac Kobrin 

(Senior Vice President and Chief Medical Officer), Andrew 

J Oakley (Executive Vice President and Chief Financial Officer), 

Otto Schwarz (Executive Vice President and Chief 

Operating Officer) 

PRINCIPAL ACTIVITIES: Bio-pharmaceutical company focusing 

on the research, development and marketing of 

synthetic small molecule drugs to treat and prevent diseases 

related to the endothelium. Actelion Ltd is the holding 

and finance company of the Group. Actelion Pharmaceuticals 

Ltd, based in Allschwil, a 100% subsidiary of Actelion 

Ltd, is in charge of the discovery, development, registration, 

production, quality assurance, safety, marketing coordination, 

group management and coordination. Actelion 

Pharmaceuticals Ltd further holds the intellectual property 

rights of the Group 

Trade Names: Tracleer (R), Ventavis (R), Zavesca (R) 

Subsidiary Companies: (100% owned unless stated): Actelion 

Clinical Research Inc (USA); Actelion Cyprus Ltd 

(Cyprus); Actelion Finance SCA (Luxembourg); Actelion 

Ilac Ticaret LS (Turkey); Actelion Luxembourg SARL (Luxembourg); 

Actelion One SA (Luxembourg); Actelion Participation 

GmbH; Actelion Partners SNC (Luxembourg); 

Actelion Pharma Polska Sp zoo (Poland); Actelion Pharma 

Schweiz AG; Actelion Pharmaceuticals Australia Pty Ltd 

(Australia); Actelion Pharmaceuticals Austria GmbH (Austria); 

Actelion Pharmaceuticals Belgium NV (Belgium); 

Actelion Pharmaceuticals Canada Inc (Canada); Actelion 

Pharmaceuticals CZ sro (Czech Republic); Actelion Pharmaceuticals 

Deutschland GmbH (Germany); Actelion Pharmaceuticals 

do Brasil Ltda (Brazil); Actelion Pharmaceuticals 

España SL (Spain); Actelion Pharmaceuticals France SASU 

(France); Actelion Pharmaceuticals Hellas SA (Greece); 

Actelion Pharmaceuticals Hungaria LLC (Hungary); Actelion 

Pharmaceuticals India Private Ltd (India); Actelion Pharmaceuticals 

Israel Ltd (Israel); Actelion Pharmaceuticals 

Italia Srl (Italy); Actelion Pharmaceuticals Japan Ltd (Japan); 

Actelion Pharmaceuticals Korea Ltd (South Korea); Actelion 

Pharmaceuticals Ltd (CH); Actelion Pharmaceuticals Mexico 

SA de CV (Mexico); Actelion Pharmaceuticals Nederland BV 

(Netherlands); Actelion Pharmaceuticals Portugal (Portugal); 

Actelion Pharmaceuticals RUS LLC (Russia); Actelion Pharmaceuticals 

(Shanghai) Company Ltd (People’s Republic of 

China); Actelion Pharmaceuticals Singapore Pte Ltd (Singapore); 

Actelion Pharmaceuticals SK sro (Slovakia); Actelion 

Pharmaceuticals Sverige AB (Sweden); Actelion Pharmaceuticals 

Taiwan Ltd (Taiwan); Actelion Pharmaceuticals UK 

Ltd (UK); Actelion Pharmaceuticals US Inc (USA); Actelion 

Re SA (Luxembourg); Actelion Registration Ltd (UK); Actelion 

US Holding Company (USA); Areus Inc (USA); CoTherix 

Inc (USA) 

Auditors: Ernst & Young AG 

Ticker Symbol: ATLN 

Stock Exchange: Swiss 

ISIN: CH0010532478 



No of Employees: 1,600 (Group worldwide) 

Financial Information: Consolidated figures 

31.12.10 31.12.11 

SF’000 SF’000 

Revenue 1,928,969 1,796,063 

Profit (loss) before tax 440,861 (69,301) 

Profit (loss) after tax 390,557 (146,319) 

Earnings (loss) per share 3.28SF (1.23SF) 

Share capital 64,912 65,232 


03593 

ADD TECHNOLOGIES AG 

Former name: ADD Advanced Drug Delivery Technologies 

AG 

Address: Kägenstrasse 17, 4153 Reinach 



Company email: info@addtechnologies.com 

Website: www.addtechnologies.com 


Board of Directors: Reinhard Nowak (Chairman), Dr Hans 

Leuenberger (Director), Hans Rudolf Lötscher (Director), Jay 

Nowak (Director) 

PRINCIPAL ACTIVITIES: Development, manufacture and 

sale of enhanced pharmaceutical and biopharmaceutical 

multiparticulate products 

Company History: The company was previously known as 

ADD Advanced Drug Delivery Technologies AG 

Auditors: Testor Treuhand 


Principal Shareholders: Glatt Pharmaceutical Services 

03594 

ADDEX PHARMACEUTICALS LTD 

Addex Pharma SA 

Address: 12 chemin des Aulx, 1228 Plans-les-Ouates 



Company email: addex-hr@addexpharma.com 

Website: www.addexpharma.com 


Board of Directors: André J Mueller (Chairman), Vincent 

Lawton (Vice Chairman), Andrew Galazka (Director), Dr 

Raymond Hill (Director), Dr Hoyoung Huh (Director), Oleg 

Nodelman (Director), Antoine Papiernik (Director) 

Management: Dr Bharatt Chowrira (President and Chief 

Executive Officer), Tim Dyer (Chief Financial Officer), Dr 

Laurent Galibert (Head of Metabolism and Inflammation 

Projects), Charlotte Keywood (Chief Medical Officer), Robert 

Lütjens (Head of Biology), Chris Maggos (Head of Investor 

Relations and Communication), Dr Sonia Poli (Head of 

Non-Clinical Development and CNS Projects), Tatiana Pont- 

Carteret (Head of Human Resources), Jean-Philippe Rocher 

(Head of Chemistry) 

PRINCIPAL ACTIVITIES: Development, production and marketing 

of drugs and medicines for the treatment of addictions, 

physical ailments and neuropsychiatric conditions. The 

company develops allosteric modulators, small molecule 

therapeutic agents that may offer more sophisticated ways 

to normalise biological signalling perturbed by disease 

compared to classical “orthosteric” agonist or antagonist 

drugs. Addex focuses on the discovery and development 

of allosteric modulators which target G-Protein Coupled

04139 INTERVET COLOMBIA LTDA COLOMBIA 


31.12.09 31.12.10 

COP’000 COP’000 




Share capital 38,409,684 38,409,684 


04139 

INTERVET COLOMBIA LTDA 

Address: Avenida Carrera 68 N0 17-64, Costado Occidental, 

Bogotá DC 



Website: www.intervet.com.co 

Company Registration Number: 830015923 

Management: Angelo Bolis Delair (Representante Legal), 

Steven Koehler (Gerente), Ricardo Rodriguez Chala (Contador), 

Michiel Stijn (Gerente) 

PRINCIPAL ACTIVITIES: Wholesale trade in animal healthcare 

products 

Parent Company: Merck & Co Inc., USA 

Status: Limited Liability Company 

Principal Shareholders: Merck & Co Inc., USA 


31.12.09 31.12.10 

COP’000 COP’000 



Profit after tax 943,607 3,505,693 

Share capital 777,550 777,550 


04140 

JOHNSON & JOHNSON DE COLOMBIA S.A. 

J&J DE COLOMBIA SA 

Address: Apartado Postal 6530, Calle 15 No.31-146, 

Yumbo, Valle del Cauca 



Website: www.jnjcolombia.com.co 


Board of Directors: Martha Lucia Echeverry Piñeres (Director), 

Walter Grundy (Director), Adolfo Ignacio Ibarra Garcia 

(Director), Rosana Padilla Guevara (Representante Legal), 

Álvaro Palacio Restrepo (Gerente) 

Management: Luis Casallas Jimenez (Contador) 

PRINCIPAL ACTIVITIES: Manufacture of toiletries and pharmaceuticals 

Parent Company: Johnson & Johnson, USA 

Status: Non Quoted Public Company 

Principal Shareholders: Johnson & Johnson, USA 

Date of Establishment: 5 December 1962 


31.12.09 31.12.10 

COP’000 COP’000 




Share capital 1,852,846 1,852,846 


04141 

LABORATORIOS BAXTER S.A. 

Address: Apartado Postal 2446, Calle 36 No.2C-22, Cali 

International tel: +57 (2) 444 7275; +57 (2) 444 7000 


Website: www.latinoamerica.baxter.com/colombia 


Management: Mario Ciardelli Medina (Representante Legal), 

César Augusto González Ospina (Gerente), Carlos Alberto 

Roldan Aragon (Gerente), Hector Fauro Vargas Gutierrez 

(Contador) 


Parent Company: Baxter International Inc, USA 


Principal Shareholders: Baxter International Inc, USA 

536 


31.12.09 31.12.10 

COP’000 COP’000 




Share capital 1,000,926 1,000,926 


04142 

MERCK S.A. 

Address: Calle 10 No. 65 28, Bogotá DC 



Company email: mcsa@merck.com.co 

Website: www.merck.com.co 


Board of Directors: Hernán Alfonso Briceño Rodríguez (Representante 

Legal), Carlos Arturo García Montoya (Director), 

Esteban Serrano Luciano (Director) 

Management: Luz Mery López Lagos (Gerente), Gladys Stella 

Lorenzana Huertas (Contador) 

PRINCIPAL ACTIVITIES: Manufacture of chemicals for use in 

the pharmaceutical and of pharmaceutical preparations 

Parent Company: Merck KGaA (02705) 


Principal Shareholders: Merck KGaA, Germany 




31.12.09 31.12.10 

COP’000 COP’000 




Share capital 14,356,030 14,356,030 


04143 

NOVARTIS DE COLOMBIA S.A. 

NOVARTIS 

Address: Apartado Postal 123234, Calle 11 No.65-51, 

Bogotá DC 



Website: www.novartis.com 


Board of Directors: Maria Cristina Alvarez Rodriguez (Representante 

Legal), Jean Claude Dubos (Director), Carlos 

Dicken Garcia Iragorri (Director) 

Management: Carlos Leonardo Garcia Hewitt (Gerente), 

Evelyn Peña (Contador), Guillermo José Quintero Perdomo 

(Gerente) 

PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals 

aiming to prevent and cure diseases, to ease suffering and 

to enhance the quality of life 

Parent Company: Novartis AG (03653) 


Principal Shareholders: Novartis AG, Switzerland (100%) 


31.12.09 31.12.10 

COP’000 COP’000 




Share capital 7,934,807 7,934,807 


04144 

PFIZER S.A. 

PFIZER 

Address: Avenida El Dorado No.68B-85, Bogotá DC 



Website: www.pfizer.com.co 


Board of Directors: Luis Alberto Acuña González (Director), 

Luis Fernando Molano (Director), Francisco A Rodríguez 

Rodríguez (Director) 

Management: Juan Carlos Avila Bustos (Contador), Claudia 

Johanna Bohorquez Leon (Gerente), Andres Jordan Herrera 

(Representante Legal) 


for human and veterinary use 

Parent Company: Pfizer Inc, USA 


Principal Shareholders: Pfizer Inc, USA 


31.12.09 31.12.10 

COP’000 COP’000 




Share capital 30,332,357 30,332,357 


04145 

PROCTER & GAMBLE COLOMBIA LTDA 

P & G Colombia Ltda 

Address: Apartado Postal 94611, Carrera 7 No.114-33, Piso 

12, Bogotá DC 



Website: www.pg.com 


Management: Carlos Alfredo Giraldo Aly (Representante Legal), 

Rafael Molina (Contador), Juan David Valencia Ocampo 

(Gerente), Víctor Karlo Velazquez Patron (Gerente) 

PRINCIPAL ACTIVITIES: Wholesale trade in personal care 

products, household cleaning items, laundry detergents, 

prescription drugs and disposable nappies 

Trade Names: Ariel, Pantele, Pert Plus, Camay, Crest 

Parent Company: Procter & Gamble Company, USA 

Status: Limited Liability Company 

Principal Shareholders: Procter & Gamble Company, USA 


31.12.09 31.12.10 

COP’000 COP’000 




Share capital 32,212,968 32,212,968 


04146 

PRODUCTOS ROCHE S.A. 

Address: Carrera 44 No.17-21, Bogotá DC 



Website: www.roche.com.co 


Board of Directors: Hector Feliu (Director), Rolf Erik Honger 

(Representante Legal), Jorg Michael Rupp (Director) 

Management: Rodrigo Alonso Gómez Burbano (Gerente), 

Edith Marisol López Borbón (Contador) 


Parent Company: Roche Holding AG (03668) 


Principal Shareholders: Roche Holding AG, Switzerland 

(100%) 


31.12.09 31.12.10 

COP’000 COP’000 




Share capital 26,923,689 26,923,689 


04147 

SANOFI-AVENTIS PHARMA S.A. 

SANOFI 

Address: Apartado Postal 6161, Transversal 23 N. 97-73, 

Piso 9, Bogotá DC 



Website: www.sanofi-aventis.com 


Board of Directors: Mauricio Botero Caicedo (Representante 

Legal), Stephen Edward Cobhan Scott (Director), Jesus 

Hernando Cubides Ballesteros (Director) 

Management: Giovanni Castillo Moreno (Contador), Hernando 

Suárez Ramírez (Gerente)

Alphabetical Index 

3M Australia Pty Ltd [Australia] 00480 

3M Deutschland GmbH [Germany] 02548 

3M India Limited [India] 00641 

3M Ireland Ltd [Republic of Ireland] 

03281 

3M Manufacturera Venezolana 

S.A. [Venezuela] 04265 

3M Singapore Pte Ltd [Singapore] 01538 

3M Taiwan Ltd [Taiwan] 01732 

3M United Kingdom PLC [UK ] 03719 

77 Elektronika Kft [Hungary] 02824 

A Baur & Co Ltd [Sri Lanka] 01725 

A C Nielsen [India] 00642 

A Nelson & Co Ltd [UK ] 03720 

A S Bryden & Sons (Antigua) Ltd 

[Antigua and Barbuda] 04057 

A S Bryden & Sons (Trinidad) Limited 

[Trinidad and Tobago] 04097 

A S Bugshan & Bros [Saudi Arabia] 00330 

A Vogel Bioforce AG [Switzerland] 03606 

A&D Pharma Holdings SRL [Romania] 

03334 

A. Cardoso, S.A. [Spain] 03382 

A. Menarini Industrie Farmaceutiche 

Riunite Srl [Italy] 03004 

A.S. Bryden & Sons (Barbados) Ltd 

[Barbados] 04066 

A2 Corporation Limited [New 

Zealand] 01214 

AAH Pharmaceuticals Ltd [UK ] 03721 

AAIPharma Services Corp. [USA] 04371 

Aalto Bio Reagents Ltd [Republic of 

Ireland] 03282 

Aamal Company QSC [Qatar] 00324 

Aarti Drugs Limited [India] 00643 

AB Cosmetics, s.r.o. [Slovakia] 03357 

AB Kozmetika group sro [Slovakia] 03357 

AB Sanitas [Lithuania] 03059 

AbacusBio Limited [New Zealand] 01215 

Abbot [India] 00644 

ABBOTT [Spain] 03384 

Abbott Argentina S.A. [Argentina] 03909 

Abbott Australasia Pty Limited 

[Australia] 00481 

Abbott Belgique/België [Belgium] 02084 

Abbott Científica SA [Spain] 03383 

Abbott France SAS [France] 02300 

Abbott GmbH & Co KG [Germany] 02549 

Abbott Healthcare Products BV 

[Netherlands] 03068 

Abbott Healthcare SAS [France] 02301 

Abbott India Limited [India] 00644 

Abbott Japan Co Ltd [Japan] 00962 

Abbott Korea Ltd [South Korea] 01585 

Abbott Laboratories [USA] 04372 

Abbott Laboratories A/S [Denmark] 02201 

Abbott Laboratories Argentina SA 

[Argentina] 03909 

Abbott Laboratories de Colombia 

S.A. [Colombia] 04131 

Abbott Laboratories de México, 

S.A. de C.V. [Mexico] 04172 

Abbott Laboratories (Hellas) SA 

[Greece] 02789 

Abbott Laboratories Ltd [UK ] 03722 

Abbott Laboratories (Malaysia) Sdn 

Bhd [Malaysia] 01137 

Abbott Laboratories Pakistan Limited 

[Pakistan] 01243 

Abbott Laboratories Philippines 

[Philippines] 01499 

Abbott Laboratories (Singapore) 

Pte Ltd [Singapore] 01539 

Abbott Laboratories Vascular Enterprises 

Limited [Republic of 


Abbott Laboratories, Ross Products 

Div. [USA] 04373 

Abbott Laboratories, S.A. [Spain] 03384 

Abbott Laboratórios do Brasil Ltda 

[Brazil] 03948 

Abbott Laboratorios Lda [Portugal] 03236 

Abbott Liestal AG [Switzerland] 03589 

Abbott Logistics BV [Netherlands] 03069 

Abbott Logistics BV Zwolle 

[Netherlands] 03069 

Abbott Norge AS [Norway] 03123 

Abbott Oy [Finland] 02266 

Abbott Pharmaceuticals Puerto 

Rico Ltd [Puerto Rico] 04085 

Abbott Products SA/NV [Belgium] 02083 

Abbott Products SAS [France] 02302 

ABBOTT S.A. [Colombia] 04131 

Abbott SA/NV [Belgium] 02084 

Abbott Scandinavia AB [Sweden] 03526 

Abbott Service AG [Switzerland] 03589 

Abbott South Africa (Pty) Ltd 

[South Africa] 00079 

Abbott Srl [Italy] 02938 

Abcam Plc [UK ] 03723 

Abdbullah Mohd Almadani Alghamdi 

Est [Saudi Arabia] 00385 

Abdel Moniem Group of Companies 

[Sudan] 00396 

Abdellatif Banaja & Co [Saudi Arabia] 

00386 

Abdi Ibrahim Ilaç Sanayi ve Ticaret 

AS [Turkey] 03693 

Abdullah Said Bugshan & Bros 

[Saudi Arabia] 00330 

Abdullatif MS Jamjoom & Bros 

[Saudi Arabia] 00373 

Abdulrehman Algosaibi General 

Trading Bureau [Saudi Arabia] 00331 

Abengoa, S.A. [Spain] 03385 

ABIC Biological Laboratories Ltd 

[Israel] 02885 

ABIC Veterinary Products Ltd [Israel] 

02885 

ABLE C & C Inc [South Korea] 01586 

Able Sales Company Inc. [Puerto 

Rico] 04086 

Ablynx SA/NV [Belgium] 02085 

Abraxis BioScience Inc. [USA] 04374 

Abu Shakra [Jordan] 00232 

Abu Shakra Trading Agency [Jordan] 

00232 

Aburaihan Pharmaceutical Company 

[Iran] 00932 

ACAPI [Egypt] 00174 

ACB Blocks [Russia] 01907 

Accelciors CRO and Consultancy 

Services Limited Company [Hungary] 

02825 

Accelsiors Kft [Hungary] 02825 

Alphabetical Index 

Accelsiors Kutatásszervezõ és 

Tanácsadó Szolgáltatási Kft [Hungary] 

02825 

Acciona, S.A. [Spain] 03386 

Accredo Health, Inc. [USA] 04375 

ACE BioSciences A/S [Denmark] 02202 

ACEnet [Canada] 04291 

ACES [United Arab Emirates] 00442 

Aché Laboratórios Farmacêuticos 

S.A. [Brazil] 03949 

ACI Limited [Bangladesh] 00547 

ACIdEKA, S.A. [Spain] 03387 

Acino AG [Germany] 02550 

Acino Holding AG [Switzerland] 03590 

ACNielsen Ltda [Brazil] 03950 

ACNielsen SA [Greece] 02790 

ACNielsen, a VNU business 

[Cyprus] 02159 

ACNielsen/AMER World Research 

[Cyprus] 02159 

Acorda Therapeutics Inc. [USA] 04376 

Acorn Products (Pty) Ltd [South 

Africa] 00080 

ACP Pharma S.A. [Poland] 03158 

Acraf SpA [Italy] 02939 

Acromax Dominicana S.A. [Dominican 

Republic] 04071 

Acta Service Srl [Italy] 02940 

Actavis [Switzerland] 03591 

Actavis Deutschland GmbH & Co 

KG [Germany] 02551 

Actavis EAD [Bulgaria] 02142 

Actavis Group [Switzerland] 03591 

Actavis Operations EOOD [Bulgaria] 

02143 

Actavis Pharma Development Centre 

Private Limited [India] 00645 

Actavis Romania SRL [Romania] 03333 

Actavis UK Limited [UK ] 03724 

Actelion Pharmaceuticals France 

SASU [France] 02303 

Actelion Pharmaceuticals Ltd 

[Switzerland] 03592 

Active Biotech AB [Sweden] 03527 

AD Jaka 80 Radovis [Macedonia] 01900 

AD Motors Co Ltd [South Korea] 01587 

Adamed Sp. z.o.o. [Poland] 03159 

ADCO [Egypt] 00183 

Adcock Ingram Holdings Limited 


ADD Advanced Drug Delivery 

Technologies AG [Switzerland] 03593 

ADD Technologies AG [Switzerland] 

03593 

Addex Pharma SA [Switzerland] 03594 

Addex Pharmaceuticals Ltd 

[Switzerland] 03594 

Addis Pharmaceutical Factory 

[Ethiopia] 00012 

ADI Finechem Limited [India] 00646 

ADImmune Corporation [Taiwan] 01733 

Adinath Bio-Labs Limited [India] 00647 

adinotec AG [Germany] 02552 

Adisseo France SAS [France] 02304 

ADL [India] 00643 

ADL [India] 00759 

AdnaGen GmbH [Germany] 02553 

Adnan Shalan & Co [Jordan] 00233 

Adroit Medical Systems Inc. [USA] 04377 

Advanced Biochemicals Ltd [India] 00648 

Advanced Chemical Industries Ltd 

[Bangladesh] 00547 

Advanced Enzyme Technologies 

Ltd [India] 00648 

Advanced Technology Company 

KSCC [Kuwait] 00256 

Advik Laboratories Limited [India] 00649 

Advinus Therapeutics Limited [India] 

00650 

ADWYA SA [Tunisia] 00428 

Aekyung Industrial Co Ltd [South 

Korea] 01588 

Aerocrine AB [Sweden] 03528 

Aerospace Corp. [USA] 04378 

Aerospace Equipment Corporation 

Joint Stock Company [Russia] 01908 

AES Chemunex SA [France] 02305 

AEterna Zentaris Inc. [Canada] 04292 

Aeterna Zentaris Inc. [Canada] 04293 

AFDIL [India] 00663 

Afework International Group plc 


Affitech A/S [Denmark] 02203 

Affymax Inc. [USA] 04379 

Aflofarm Fabryka Leków Sp. z.o.o. 

[Poland] 03160 

Aflofarm Farmacja Polska Sp. 

z.o.o. [Poland] 03161 

AFM SpA [Italy] 02941 

Afri Medical [Egypt] 00175 

Africom Lda [Mozambique] 00052 

AGA Healthcare SA [Brazil] 04020 

AGECA Ethiopia Company Pvt Ltd 


Agennix AG [Germany] 02554 

Aggad Investment Company [Saudi 

Arabia] 00332 

AGI Therapeutics plc [Republic of 


Agilent Technologies Deutschland 

GmbH [Germany] 02555 

Agilent Technologies Singapore 

(Holdings) Pte Ltd [Singapore] 01540 

Agilent Technologies Singapore Pte 

Ltd [Singapore] 01541 

Agis Industries (1983) Ltd [Israel] 02923 

AGOC [Sudan] 00396 

Agostini’s Ltd [Trinidad and Tobago] 

04098 

Agouron Pharmaceuticals Inc. 

[USA] 04380 

AGOWA Gesellschaft für molekularbiologische 

Technologie mbH 

[Germany] 02686 

AgResearch Limited [New 

Zealand] 01216 

Agricare Ltd [Ghana] 00020 

Agricultural Research Council 


AGRIMEX LTD Sp. z.o.o. [Poland] 03162 

Agripac S.A. [Ecuador] 04159 

Agroceres Ltda [Brazil] 03951 

Agrolab GmbH [Germany] 02556 

Agropalma S.A. [Brazil] 03952 

Agropecuaria de Guissona, S.C.L. 

[Spain] 03388 

595 

Alphabetical Index

Index by Country 

Albania 

IMI FARMA Sh.p.k. 01867 

Algeria 

Antibiotical SPA 00162 

Laboratoire Biopharm Algérie SPA 00163 

Biotic SPA 00164 

DIPROCHIM SPA 00165 

Entreprise de Distribution de Produits 

Chimiques SPA 00165 

Entreprise Nationale de Production 

Pharmaceutique 00167 

Groupe Blanky SPA 00166 

Groupe Industrial Saidal SPA 00167 

Nedromeubles SPA 00168 

Pharmal SPA 00169 

Promeuble Sarl 00170 

Sanofi-Aventis Algeria SPA 00171 

Angola 

PETROGAL Angola, Lda 00001 

Argentina 

Abbott Argentina S.A. 03909 

Abbott Laboratories Argentina SA 03909 

Air Liquide Argentina S.A. 03910 

Alcon Laboratorios Argentina S.A. 03911 

AstraZeneca Argentina S.A. 03912 

BASF Argentina S.A. 03913 

Bayer Argentina S.A. 03914 

Beiersdorf S.A. 03915 

Biocientífica S.A. 03916 

Bristol-Myers Squibb Argentina 

S.R.L. 03917 

Centro Oncológico Buenos Aires 03918 

Chemotécnica S.A. 03919 

Chemotécnica Sintyal SA 03919 

Drogueria del Sud S.A.C.I. 03920 

Elvetium SA 03926 

GlaxoSmithKline Argentina S.A. 03921 

Grifols Argentina S.A. 03922 

Grupo Sidus 03923 

Instituto Rosenbusch S.A. de Biologia 

Experimental Agropecuaria 03924 

Invap S.A. 03925 

Ivax Argentina S.A. 03926 

Johnson y Sons de Argentina 03940 

Laboratorio Elea S.A.C.I.F. y A. 03927 

Laboratorios Bagó S.A. 03928 

Laboratorios Glaxo Argentina 

S.A.C.I. 03921 

Laboratorios Phoenix S.A.I.C. y F. 03929 

L’Oréal Argentina S.A. 03930 

Medicus S.A. 03931 

Merck Química Argentina S.A.I.C. 03932 

Novartis Argentina S.A. 03933 

Novartis S.A. 03933 

NuclearLab S.R.L. 03934 

Nycomed S.A. 03935 

Pioneer Argentina SA 03936 

Quintiles Argentina SA 03937 

Productos Roche S.A.Q. e I. 03938 

Laboratorios Roemmers S.A.I.C. y 

F. 03939 

S.C. Johnson & Son de Argentina 

S.A.I.C. 03940 

Tecnolab S.A. 03941 

Unilever de Argentina S.A. 03942 

Wiener Laboratorios S.A.I.C. 03943 

Armenia 

Arpimed Pharmaceutical Enterprise 

01868 

BIO-VAR Ltd 01869 

Erevan Chemical-Pharmaceutical 

Joint Stock Company 01870 

Liqvor Pharmaceuticals 01871 

Australia 

3M Australia Pty Ltd 00480 

Abbott Australasia Pty Limited 00481 

AGT Biosciences Ltd 00497 

Alchemia Limited 00482 

Alphapharm Pty Ltd 00483 

Anadis Limited 00506 

Analytica Limited 00484 

ANSTO 00486 

Astra Pharmaceuticals Pty Ltd 00485 

AstraZeneca Pty Ltd 00485 

Ausmelt Limited 00526 

Australian Nuclear Science & 

Technology Organisation 00486 

Australian Pharmaceutical Industries 

Limited 00487 

Beiersdorf Australia Ltd 00488 

BioDiem Ltd 00489 

Bionomics Limited 00490 

Biota Holdings Limited 00491 

Blackmores Limited 00492 

Boehringer Ingelheim Pty Limited 00493 

Bristol-Myers Squibb Australia Pty 

Ltd 00494 

BTF Pty Ltd 00495 

Cellestis Limited 00496 

ChemGenex Pharmaceuticals Limited 

00497 

Circadian Technologies Limited 00498 

Clariant (Australia) Pty Ltd 00499 

CSL Limited 00500 

Eli Lilly Australia Pty Limited 00501 

Genetic Technologies Limited 00502 

GlaxoSmithKline Australia Pty Ltd 00503 

Healthzone Limited 00504 

IDT Australia Limited 00505 

Immuron Limited 00506 

Implicit Biosciences Ltd 00507 

Institute of Drug Technology Australia 

Ltd 00505 

Intervet Australia Pty Limited 00508 

S C Johnson & Son Pty Ltd 00509 

Johnson & Johnson Pacific Pty 

Limited 00510 

Lipa Pharmaceuticals Limited 00511 

McCormick Foods Australia Pty Ltd 00512 

Index by Country 

Meat & Livestock Australia Limited 00513 

Mentholatum Australasia Pty Ltd 00514 

Merck Sharp & Dohme (Australia) 

Pty Ltd 00515 

Metabolic Pharmaceuticals Limited 00516 

Calzada Limited 00516 

MLA 00513 

Monsanto Australia Limited 00517 

MSD 00515 

Nichirei Australia Pty Ltd 00518 

Nippon Steel Australia Pty Limited 00519 

Novartis Pharmaceuticals Australia 

Pty Limited 00520 

Novo Nordisk Pharmaceuticals Pty 

Limited 00521 

Novogen Limited 00522 

Nufarm Limited 00523 

Nutrimetics International Holdings 

Pty Ltd 00524 

Orica Limited 00525 

Outotec Pty Ltd 00526 

Pfizer Australia Pty Ltd 00527 

PharmaCare Laboratories Pty Limited 

00528 

Pharmaxis Ltd 00529 

Phosphagenics Limited 00530 

Prana Biotechnology Limited 00531 

Primary Health Care Ltd 00532 

Proteome Systems Limited 00545 

Provet Holdings Ltd 00533 

PZ Cussons Australia Pty Ltd 00534 

James Richardson Corporation Pty 

Ltd 00535 

Ridley Corporation Ltd 00536 

Roche Products Pty Limited 00537 

Sanofi Australia and New Zealand 00538 

Sanofi-Aventis Australia Pty Limited 

00538 

SGS Australia Pty Ltd 00539 

Sigma Company Limited 00540 

Sigma Pharmaceuticals Limited 00540 

Silex Systems Limited 00541 

Sirtex Medical Limited 00542 

Sonic Healthcare Limited 00543 

Washington H Soul Pattinson & 

Company Limited 00544 

Tyrian Diagnostics Limited 00545 

Virax Holdings Limited 00546 

Austria 

AstraZeneca Österreich GmbH 02045 

Aventis Pasteur MSD GmbH 02079 

Aventis Pharma GmbH 02080 

BASF Performance Products GmbH 02046 

Baxter Aktiengesellschaft 02047 

Bayer Austria Gesellschaft mbH 02048 

Beiersdorf Gesellschaft mbH 02049 

Boehringer Ingelheim Austria 

GmbH 02050 

Boehringer Ingelheim RCV GmbH & 

Co KG 02050 

Boehringer Ingelheim Regional 

Centre Vienna GmbH & Co KG 02050 

C Richter Ges mbH & Co KG 02074 

Parfums Christian Dior GmbH 02051 

dm drogerie markt GmbH 02052 

EBEWE Arzneimittel GmbH 02053 

EBEWE Pharma Ges mbH NfG KG 02053 

F Joh Kwizda Unternehmens- 

Verwaltungsgesellschaft mbH 02067 

Fresenius Kabi Austria GmbH 02054 

Geoconsult ZT GmbH 02055 

GKB-Bergbau GmbH 02056 

GlaxoSmithKline Österreich 02057 

GlaxoSmithKline Pharma GmbH 02057 

Guerlain Gesellschaft mbH 02058 

H Wilhelm Schaumann 

Gesellschaft mbH & Co KG 02059 

Henkel Austria Gruppe Beteiligungsverwaltung 

Gesellschaft 

mbH 02060 

Henkel CEE Gesellschaft mbH 02060 

Henkel Central Eastern Europe 

Gesellschaft mbH 02060 

Herba Chemosan Apotheker-AG 02061 

Hestag Arzneiwarengrosshandlung 

Ges mbH 02072 

Hoffmann-La Roche Wien Ges 

mbH 02075 

Intercell AG 02062 

INTERCELL Biomedizinische 

Forschungs- und Entwicklungs 

AG 02062 

Intervet GesmbH 02063 

Jacoby Pharmazeutika Aktiengesellschaft 

02064 

Janssen-Cilag Pharma GmbH 02065 

Johnson & Johnson Gesellschaft 

mbH 02066 

Kwizda Holding GmbH 02067 

Lohmann & Rauscher GmbH 02068 

Novartis Pharma GmbH 02069 

Nycomed Austria GmbH 02070 

ÖIAG-Bergbauholding AG 02056 

Österreichische Unilever GesmbH 02082 

P & G Austria GmbH 02073 

Parfums Givenchy c/o Guerlain 

GesmbH 02058 

Pfizer Corporation Austria 

Gesellschaft mbH 02071 

Phoenix Arzneiwarengrosshandlung 

GmbH 02072 

Procter & Gamble Austria GmbH 02073 

Richter Pharma AG 02074 

Roche Austria GmbH 02075 

Roche Diagnostics GmbH 02076 

Sandoz GmbH 02077 

Sanochemia Pharmazeutika AG 02078 

Sanofi Pasteur MSD GmbH 02079 

Sanofi-Aventis Österreich 02080 

Sanofi-Aventis GmbH 02080 

Sanova Pharma GesmbH 02081 

Schaumann Holding Ges mbH 02059 

Unilever Austria GmbH 02082 

Azerbaijan 

Azerbaijan Petroleum Machinery 

Scientific Research and Development 

Institute 01872 

Azinmash 01872 

SOCAR 01873 

625 

Index by Country

Sample pages - Gale

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?